Diagnostic approach to patients with suspected vasculitis

Suresh, E.
August 2006
Postgraduate Medical Journal;Aug2006, Vol. 82 Issue 970, p483
Academic Journal
Vasculitis presents several diagnostic challenges. Firstly, patients could present with protean clinical manifestations with a wide spectrum ranging from isolated cutaneous vasculitis to multisystem involvement. Secondly, there are several medical conditions that could mimic the presentation of vasculitis. The range of differential diagnosis is therefore broad. Thirdly, vasculitis could occur as a primary disorder or be secondary to various medical conditions. It becomes important to differentiate them, as treatment of some forms of vasculitis such as those that are secondary to infection or drugs, is different from that of primary vasculitis. Fourthly, there are several different forms of vasculitis. Some are benign and self limiting, while others have the potential to threaten vital organ function and life. It follows that a rational approach is required during evaluation of patients with suspected vasculitis.


Related Articles

  • Differential diagnosis of ischemic stroke: Uncommon causes. Bruno, Askiel // Geriatrics;Mar1993, Vol. 48 Issue 3, p31 

    The article presents information on the uncommon causes of differential diagnosis of ischemic stroke. Uncommon causes of ischemic stroke that must nonetheless be considered in the differential diagnosis include vasculitis, hypercoagulable disorders, paradoxical cerebral embolism, arterial...

  • Management of anesthesia in henoch schonlein purpura: a case report. Koca, Erdinc // Journal of Turgut Ozal Medical Center;2016, Vol. 23 Issue 4, p457 

    Henoch schonlein purpura (HSP) is the most common kind of acute small-vessel vasculitis especially affecting children. It is initiated by deposition of immune complexes as responses to infections such as group A streptococci, mycoplasma, Epstein -Barr, and Varicella zoster. HSP is characterized...

  • COMMENTARY: Plasma exchange led to a higher rate of renal recovery than intravenous methylpredisolone in severe vasculitis. Lionaki, Sofia // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p11 

    The author comments on the study which examines the effect of cyclophosphamide and oral prednisolone in treating patients with severe vasculitis. Study suggests that when people with severe vasculitis are being treated with methylprednisolone, adding plasma exchange to treatment should be...

  • Plasma exchange led to a higher rate of renal recovery than intravenous methylpredisolone in severe vasculitis.  // ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p11 

    The article presents a study which examines the effect of cyclophosphamide and oral prednisolone in treating patients with severe vasculitis. According to the study, patients with severe vasculitis who received cyclophosphamide and prednisolone, plasma exchange led to greater renal recovery than...

  • Cogan's Syndrome: A Rare Cause of Meningoencephalitis. Pysden, Karen S.; Long, Vernon; Ferrie, Colin D. // Journal of Child Neurology;Jun2009, Vol. 24 Issue 6, p753 

    We report a 14-year-old boy who presented with meningoencephalitis. Other features particularly auditory, vestibular, and ocular lead to the diagnosis of Cogan's syndrome. Treatment with prednisolone resulted in a rapid improvement and recovery of his hearing. Cogan's syndrome is a rare primary...

  • Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Millet, Arnaud; Pederzoli-Ribeil, Magali; Guillevin, Loïc; Witko-Sarsat, Véronique; Mouthon, Luc // Postgraduate Medical Journal;May2014, Vol. 90 Issue 1063, p290 

    Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides are a heterogeneous group of diseases corresponding to necrotising inflammation of small vessels with a wide range of clinical presentations. At least two of the diseases are believed to exhibit a common ground of...

  • Predictive value of antibodies to cyclic citrullinated peptide in patients with early arthritis. Ateş, Aşkın; Karaaslan, Yaşar; Aksaray, Sebahat // Clinical Rheumatology;Apr2007, Vol. 26 Issue 4, p499 

    The objective of this study was to determine the diagnostic value for rheumatoid arthritis (RA) of antibodies to cyclic citrullinated peptides (anti-CCP) in patients with early arthritis and vasculitis. Sixty-four adult patients with early arthritis and disease duration of less than 4 months...

  • Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis. de Groot, Kirsten; Harper, Lorraine; Jayne, David R. W.; Suarez, Luis Felipe Flores; Gregorini, Gina; Gross, Wolfgang L.; Luqmani, Rashid; Pusey, Charles D.; Rasmussen, Niels; Sinico, Renato A.; Tesar, Vladimir; Vanhille, Philippe; Westman, Kerstin; Savage, Caroline O. S. // Annals of Internal Medicine;5/19/2009, Vol. 150 Issue 10, p670 

    Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)—associated vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily oral cyclophosphamide for induction of remission. Design: Randomized, controlled trial. Random assignments...

  • Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis. Holding, Stephen; Fisher, Victoria J; Abuzakouk, Mohamed // Annals of Clinical Biochemistry;Mar2015, Vol. 52 Issue 2, p297 

    The article presents a study which aims to quantify the incidence of antibody switching. It states that the study reviewed all anti-neutrophil cytoplasmic antibody (ANCA) results in Hull and East Yorkshire Hospitals National Health Service Trust from January 2000 to August 2012. It is inferred...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics